EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR)

CUSIP: G3141W106

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / SHS
Total 13F shares
6,619,128
Share change
+1,585,732
Total reported value
$64,600,984
Price per share
$9.76
Number of holders
38
Value change
+$15,464,416
Number of buys
16
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP G3141W106?
CUSIP G3141W106 identifies EUCR - EUCRATES BIOMEDICAL ACQU COR - SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR) as of Q4 2021

As of 31 Dec 2021, EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,619,128 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BlackRock Inc., 683 Capital Management, LLC, D. E. Shaw & Co., Inc., Hudson Bay Capital Management LP, Altium Capital Management LP, CVI Holdings, LLC, Eisler Capital (UK) Ltd., KINGDON CAPITAL MANAGEMENT, L.L.C., and EcoR1 Capital, LLC. This page lists 38 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.